S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
OGN · Organon & Co.
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
$13.74
-0.01
(-0.07%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$13.74
$13.74
$13.77
52-WEEK RANGE
$13.74
$5.69
$13.83
What's happening
- OGN is down 0.07% today, trading at $13.74. — Live quote
- It's trading within 3% of its 52-week high ($13.83). (Finnhub fundamentals)
- Volume today (130,604) is well below its 3-month average of 2,607,310. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $0.85 actual vs. $0.93 estimated (-8.3%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 0
Buy 0
Hold 7
Sell 5
Strong sell 1
Aggregate ratings for 2026-10-01 (13 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
OGN
+91.91%
vs S&P 500
+79.13%
1-YEAR RETURN
OGN
+48.92%
vs S&P 500
+34.36%
6-MONTH RETURN
OGN
+47.48%
3-MONTH RETURN
OGN
+1.85%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$0.85
Est. $0.93
MISS -8.3%
2026-04-26 (Q1 2026)
$0.71
Est. $0.84
MISS -15.2%
2026-01-26 (Q4 2025)
$0.63
Est. $0.73
MISS -14.2%
2025-10-26 (Q3 2025)
$1.01
Est. $0.95
BEAT +6.8%
Valuation Measures & Ratios
Enterprise Value4$11.03B
Forward P/E53.83
PEG Ratio60.57
Price / Sales (TTM1)0.59
Price / Book73.53
EV4 / Revenue1.80
EV4 / EBITDA16.98
Profit Margin3.41%
Operating Margin8.01%
Return on Equity (ROE8)23.44%
Return on Assets (ROA9)1.59%
Avg Volume (3M)2,607,310
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $3.65B | $1.58B | $2.78B | $2.48B | $3.88B |
| P/E | 6.54 | 2.94 | 3.70 | 3.16 | 4.60 |
| Price/Sales | 0.59 | 0.26 | 0.44 | 0.39 | 0.61 |
| Price/Book | 3.63 | 1.75 | 3.07 | 3.38 | 7.15 |
| EV/Revenue | 1.77 | 1.46 | 1.73 | 1.69 | 1.94 |
| ROE | 55.57% | 59.58% | 82.89% | 107.23% | 155.35% |
| ROA | 4.24% | 4.14% | 5.54% | 5.82% | 6.40% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short18,961,096
Change from Prior Settlement+8.17%
% of Float—
Days to Cover (Short Ratio)9.05
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Trailing 52-week price return is +48.9%. Finnhub market metrics ↗
- Latest SEC filing is Form 4, filed 2026-08-12; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -2.3% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 3.4%. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on OGN
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.56B | $1.46B | $1.60B | $1.59B | $1.51B | $1.58B | $1.61B | $1.62B |
| Gross profit | $847.0M | $783.0M | $857.0M | $874.0M | $841.0M | $923.0M | $939.0M | $957.0M |
| Net income | $108.0M | $146.0M | $160.0M | $145.0M | $87.0M | $359.0M | $195.0M | $201.0M |
| EPS (diluted) | $0.40 | $0.55 | $0.61 | $0.56 | $0.33 | $1.38 | $0.75 | $0.78 |
| EPS (basic) | $0.41 | $0.56 | $0.61 | $0.56 | $0.34 | $1.39 | $0.76 | $0.78 |
| Net margin | $7 | $10 | $10 | $9 | $6 | $23 | $12 | $12 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $13.18B | $13.00B | $12.87B | $13.55B | $13.50B | $13.16B | $13.10B | $12.75B |
| Total liabilities | $12.17B | $12.09B | $12.12B | $12.65B | $12.77B | $12.61B | $12.63B | $12.26B |
| Stockholders' equity | $1.01B | $903.0M | $752.0M | $906.0M | $733.0M | $542.0M | $472.0M | $493.0M |
| Total current assets | $5.11B | $4.93B | $4.35B | $4.70B | $4.62B | $4.37B | $4.35B | $4.76B |
| Total current liabilities | $2.62B | $2.50B | $2.39B | $2.68B | $2.80B | $2.62B | $2.72B | $2.79B |
| Cash & equivalents | $1.13B | $1.12B | $574.0M | $672.0M | $599.0M | $547.0M | $675.0M | $763.0M |
| Accounts receivable | $1.49B | $1.38B | $1.33B | $1.48B | $1.48B | $1.46B | $1.36B | $1.69B |
| Inventory | $1.35B | $1.37B | $1.41B | $1.49B | $1.45B | $1.36B | $1.32B | $1.38B |
| Other current assets | $1.14B | $1.06B | $1.03B | $1.06B | $1.08B | $1.00B | $994.0M | $925.0M |
| Property, plant & equipment | $1.28B | $1.28B | $1.30B | $1.29B | $1.27B | $1.20B | $1.17B | $1.20B |
| Goodwill | $4.15B | $4.15B | $4.15B | $4.68B | $4.68B | $4.68B | $4.68B | $4.60B |
| Intangible assets | $1.11B | $1.10B | $1.13B | $1.34B | $1.36B | $1.42B | $1.41B | $763.0M |
| Accounts payable | $1.05B | $983.0M | $952.0M | $1.07B | $1.07B | $1.01B | $1.15B | $1.09B |
| Short-term debt | — | — | — | — | — | $20.0M | $20.0M | $10.0M |
| Long-term debt | $8.48B | $8.55B | $8.63B | $8.78B | $8.78B | $8.94B | $8.86B | $8.74B |
| Other non-current liabilities | $1.03B | $984.0M | $1.01B | $1.12B | $1.12B | $994.0M | $977.0M | $674.0M |
| Common stock & paid-in capital | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M |
| Retained earnings | $1.35B | $1.25B | $1.11B | $1.32B | $1.16B | $1.03B | $1.01B | $975.0M |
| Accumulated other comprehensive income (loss) | -$548.0M | -$539.0M | -$527.0M | -$574.0M | -$572.0M | -$617.0M | -$649.0M | -$571.0M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $107.0M | $225.0M | $141.0M | $264.0M | $220.0M | $75.0M | $390.0M | $141.0M |
| Investing cash flow | -$76.0M | $386.0M | -$65.0M | -$115.0M | -$38.0M | -$172.0M | -$296.0M | -$75.0M |
| Financing cash flow | -$12.0M | -$38.0M | -$187.0M | -$76.0M | -$223.0M | -$75.0M | -$82.0M | -$78.0M |
| Free cash flow | $65.0M | $188.0M | $96.0M | $218.0M | $181.0M | $43.0M | $335.0M | $99.0M |
| Capital expenditures | $42.0M | $37.0M | $45.0M | $46.0M | $39.0M | $32.0M | $55.0M | $42.0M |
| Share-based compensation | $25.0M | $19.0M | $7.0M | $24.0M | $22.0M | $24.0M | $26.0M | $25.0M |
| Deferred income taxes | $16.0M | $3.0M | $30.0M | $40.0M | $10.0M | -$17.0M | $10.0M | -$196.0M |
| Change in accounts receivable | $111.0M | $65.0M | -$160.0M | $5.0M | -$9.0M | $85.0M | -$341.0M | $46.0M |
| Change in inventory | $15.0M | $9.0M | -$81.0M | $63.0M | $34.0M | -$3.0M | $31.0M | $61.0M |
| Dividends paid | $6.0M | $5.0M | $4.0M | $3.0M | $10.0M | $71.0M | $74.0M | $74.0M |
| Debt issued | $0 | $0 | $325.0M | $300.0M | $340.0M | $90.0M | $150.0M | $0 |
| Debt repaid | $0 | $32.0M | $507.0M | $372.0M | $541.0M | $93.0M | $152.0M | $2.0M |
| Tax withholding on stock comp | $6.0M | $1.0M | $1.0M | $1.0M | $12.0M | $1.0M | $4.0M | $2.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B |
| Gross profit | $3.31B | $3.71B | $3.75B | $3.88B | — |
| Net income | $187.0M | $864.0M | $1.02B | $917.0M | $1.35B |
| EPS (diluted) | $0.72 | $3.33 | $3.99 | $3.59 | $5.31 |
| EPS (basic) | $0.72 | $3.36 | $4.01 | $3.61 | $5.33 |
| Net margin | $3 | $13 | $16 | $15 | $21 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $12.87B | $13.10B | $12.06B | $10.96B | $10.68B |
| Total liabilities | $12.12B | $12.63B | $12.13B | $11.85B | — |
| Stockholders' equity | $752.0M | $472.0M | -$70.0M | -$892.0M | -$1.51B |
| Total current assets | $4.35B | $4.35B | $4.51B | $3.93B | $3.76B |
| Total current liabilities | $2.39B | $2.72B | $2.92B | $2.51B | $2.60B |
| Cash & equivalents | $574.0M | $675.0M | $693.0M | $706.0M | $737.0M |
| Accounts receivable | $1.33B | $1.36B | $1.74B | $1.48B | $1.38B |
| Inventory | $1.41B | $1.32B | $1.31B | $1.00B | $915.0M |
| Other current assets | $1.03B | $994.0M | $756.0M | $747.0M | $726.0M |
| Property, plant & equipment | $1.30B | $1.17B | $1.18B | $1.02B | $973.0M |
| Goodwill | $4.15B | $4.68B | $4.60B | $4.60B | $4.60B |
| Intangible assets | $1.13B | $1.41B | $533.0M | $649.0M | $651.0M |
| Accounts payable | $952.0M | $1.15B | $1.31B | $1.13B | $1.38B |
| Short-term debt | — | $20.0M | $9.0M | $8.0M | $9.0M |
| Long-term debt | $8.63B | $8.86B | $8.75B | $8.90B | $9.12B |
| Other non-current liabilities | $1.01B | $977.0M | $412.0M | $411.0M | $463.0M |
| Common stock & paid-in capital | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M |
| Retained earnings | $1.11B | $1.01B | $443.0M | -$331.0M | -$998.0M |
| Accumulated other comprehensive income (loss) | -$527.0M | -$649.0M | -$541.0M | -$564.0M | -$513.0M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | $700.0M | $939.0M | $799.0M | $858.0M | — |
| Investing cash flow | -$390.0M | -$513.0M | -$260.0M | -$420.0M | — |
| Financing cash flow | -$561.0M | -$368.0M | -$569.0M | -$433.0M | — |
| Free cash flow | $538.0M | $764.0M | $548.0M | $662.0M | — |
| Capital expenditures | $162.0M | $175.0M | $251.0M | $196.0M | $192.0M |
| Share-based compensation | $77.0M | $105.0M | $101.0M | $75.0M | $59.0M |
| Deferred income taxes | $63.0M | -$160.0M | -$485.0M | -$18.0M | -$288.0M |
| Change in accounts receivable | -$79.0M | -$383.0M | $212.0M | $123.0M | $277.0M |
| Change in inventory | $13.0M | $131.0M | $230.0M | $220.0M | $138.0M |
| Dividends paid | $88.0M | $297.0M | $294.0M | $290.0M | $145.0M |
| Debt issued | $1.05B | $1.19B | $80.0M | $0 | $9.47B |
| Debt repaid | $1.51B | $1.20B | $338.0M | $108.0M | $112.0M |
| Tax withholding on stock comp | $15.0M | $22.0M | $17.0M | $11.0M | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding OGN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-29 to 2026-08-11
Recent transactions
- Insiders have net bought 11,687 shares over the last 182 days, across 1 purchase and 1 sale.
- Most recent: Arjona Ferreira Juan Camilo (Head of R&D & CMO) — Option exercise of 11,519 shares on 2026-08-11.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)26,448 sh(1 txns)
Sales (open market)14,761 sh(1 txns)
Net Shares+11,687
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Arjona Ferreira Juan Camilo | Head of R&D & CMO | Option exercise | 2026-08-11 | 11,519 |
| Drinane Juliana Papa | Head of Mfg & Supply | Open market sale | 2026-08-05 | 14,761 |
| Holzbaur Lynette | SVP and Corporate Controller | Open market purchase | 2026-05-06 | 26,448 |
| Karp Daniel | Executive VP, Corp. Dev. | Option exercise | 2026-03-31 | 11,338 |
| Stahler Rachel A | Chief Information Officer | Option exercise | 2026-03-31 | 6,555 |
| WALSH MATTHEW M | Chief Financial Officer | Option exercise | 2026-03-31 | 12,047 |
| Falcione Aaron | Chief Human Resources Officer | Option exercise | 2026-03-31 | 6,732 |
| Weaver Kirke | Gen. Counsel & Corp. Secy. | Option exercise | 2026-03-31 | 6,201 |
| Nisita Vittorio | Head of Global Business Svcs | Option exercise | 2026-03-31 | 4,606 |
| Morrissey Joseph T. Jr. | Interim CEO | Option exercise | 2026-03-31 | 7,795 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-11 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Option exercise | 11,519 | $0.00 |
| 2026-08-11 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Tax withholding | 4,134 | $13.62 |
| 2026-08-05 | Drinane Juliana Papa | Head of Mfg & Supply | Open market sale | 14,761 | $13.57 |
| 2026-05-06 | Holzbaur Lynette | SVP and Corporate Controller | Open market purchase | 26,448 | $13.35 |
| 2026-03-31 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Option exercise | 6,378 | $0.00 |
| 2026-03-31 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Tax withholding | 2,185 | $5.70 |
| 2026-03-31 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Option exercise | 10,073 | $0.00 |
| 2026-03-31 | Drinane Juliana Papa | Interim Head of Mfg & Supply | Tax withholding | 3,451 | $5.70 |
| 2026-03-31 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Option exercise | 13,431 | $0.00 |
| 2026-03-31 | Arjona Ferreira Juan Camilo | Head of R&D & CMO | Tax withholding | 4,820 | $5.70 |
| 2026-03-31 | Karp Daniel | Executive VP, Corp. Dev. | Option exercise | 11,338 | $0.00 |
| 2026-03-31 | Karp Daniel | Executive VP, Corp. Dev. | Tax withholding | 3,554 | $5.70 |
| 2026-03-31 | Karp Daniel | Executive VP, Corp. Dev. | Option exercise | 6,715 | $0.00 |
| 2026-03-31 | Karp Daniel | Executive VP, Corp. Dev. | Tax withholding | 2,105 | $5.70 |
| 2026-03-31 | Stahler Rachel A | Chief Information Officer | Option exercise | 6,555 | $0.00 |
| 2026-03-31 | Stahler Rachel A | Chief Information Officer | Tax withholding | 2,246 | $5.70 |
| 2026-03-31 | Stahler Rachel A | Chief Information Officer | Option exercise | 12,312 | $0.00 |
| 2026-03-31 | Stahler Rachel A | Chief Information Officer | Tax withholding | 4,217 | $5.70 |
| 2026-03-31 | WALSH MATTHEW M | Chief Financial Officer | Option exercise | 12,047 | $0.00 |
| 2026-03-31 | WALSH MATTHEW M | Chief Financial Officer | Tax withholding | 4,127 | $5.70 |
| 2026-03-31 | WALSH MATTHEW M | Chief Financial Officer | Option exercise | 21,546 | $0.00 |
| 2026-03-31 | WALSH MATTHEW M | Chief Financial Officer | Tax withholding | 7,380 | $5.70 |
| 2026-03-31 | Falcione Aaron | Chief Human Resources Officer | Option exercise | 6,732 | $0.00 |
| 2026-03-31 | Falcione Aaron | Chief Human Resources Officer | Tax withholding | 2,306 | $5.70 |
| 2026-03-31 | Falcione Aaron | Chief Human Resources Officer | Option exercise | 11,193 | $0.00 |
| 2026-03-31 | Falcione Aaron | Chief Human Resources Officer | Tax withholding | 3,834 | $5.70 |
| 2026-03-31 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Option exercise | 6,201 | $0.00 |
| 2026-03-31 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Tax withholding | 1,767 | $5.70 |
| 2026-03-31 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Option exercise | 12,312 | $0.00 |
| 2026-03-31 | Weaver Kirke | Gen. Counsel & Corp. Secy. | Tax withholding | 3,508 | $5.70 |
| 2026-03-31 | Nisita Vittorio | Head of Global Business Svcs | Option exercise | 4,606 | $0.00 |
| 2026-03-31 | Nisita Vittorio | Head of Global Business Svcs | Tax withholding | 1,578 | $5.70 |
| 2026-03-31 | Nisita Vittorio | Head of Global Business Svcs | Option exercise | 8,394 | $0.00 |
| 2026-03-31 | Nisita Vittorio | Head of Global Business Svcs | Tax withholding | 2,875 | $5.70 |
| 2026-03-31 | Holzbaur Lynette | SVP and Corporate Controller | Option exercise | 4,252 | $0.00 |
| 2026-03-31 | Holzbaur Lynette | SVP and Corporate Controller | Tax withholding | 1,212 | $5.70 |
| 2026-03-31 | Holzbaur Lynette | SVP and Corporate Controller | Option exercise | 6,715 | $0.00 |
| 2026-03-31 | Holzbaur Lynette | SVP and Corporate Controller | Tax withholding | 1,914 | $5.70 |
| 2026-03-31 | Morrissey Joseph T. Jr. | Interim CEO | Option exercise | 7,795 | $0.00 |
| 2026-03-31 | Morrissey Joseph T. Jr. | Interim CEO | Tax withholding | 2,221 | $5.70 |
| 2026-03-31 | Morrissey Joseph T. Jr. | Interim CEO | Option exercise | 16,789 | $0.00 |
| 2026-03-31 | Morrissey Joseph T. Jr. | Interim CEO | Tax withholding | 4,784 | $5.70 |
| 2026-03-29 | Stahler Rachel A | Chief Information Officer | Option exercise | 8,200 | $0.00 |
| 2026-03-29 | Stahler Rachel A | Chief Information Officer | Tax withholding | 2,809 | $5.84 |
| 2026-03-29 | Holzbaur Lynette | SVP and Corporate Controller | Option exercise | 5,319 | $0.00 |
| 2026-03-29 | Holzbaur Lynette | SVP and Corporate Controller | Tax withholding | 1,516 | $5.84 |
| 2026-03-29 | Karp Daniel | Executive VP, Corp. Dev. | Option exercise | 14,184 | $0.00 |
| 2026-03-29 | Karp Daniel | Executive VP, Corp. Dev. | Tax withholding | 4,446 | $5.84 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:47 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-08-12 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-05 | 4 | 2026-08-05 | View on SEC.gov → |
| 2026-07-31 | 8-K | 2026-07-31 | View on SEC.gov → |
| 2026-07-31 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-07-23 | 8-K | 2026-07-23 | View on SEC.gov → |
| 2026-07-17 | 8-K | 2026-07-17 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-12 | View on SEC.gov → |
| 2026-06-15 | 4 | 2026-06-12 | View on SEC.gov → |
Recent news
Headlines about OGN (Organon & Co.). Links open the publisher — we don’t host full articles.
-
Organon & Co. (OGN) Stock Forecasts
Yahoo Finance · 2026-10-22 -
Organon & Co. (OGN) stock price, news, quote and history
Yahoo Finance Singapore · 2026-10-20 -
Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
Yahoo · 2026-10-19 -
OGN Nov 2026 14.000 call (OGN261120C00014000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-19 -
OGN Nov 2026 13.000 call (OGN261120C00013000) Interactive Stock Chart
Yahoo! Finance Canada · 2026-10-18 -
Origin Enterprises plc (OGN) Reissues 1,323 Treasury Shares to Fulfill UK Savings Related Share Option Scheme
Kalkine Media · 2026-10-16 -
Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting
Yahoo · 2026-10-16 -
Organon To Present Data From Its Current Phase 3 Trial Of MIUDELLA Intrauterine Device At 2026 Society Of Family Planning Annual Meeting
Benzinga · 2026-10-16
No headlines in this category right now — try “All”.